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a b s t r a c t
Van Wyk-Grumbach Syndrome (VWGS) is a constellation of symptoms including precocious puberty
without adrenarche, delayed bone age, ovarian cysts, and hypothyroidism. We report here a four-year-
old Down Syndrome patient who presented for evaluation of abdominal distension, vaginal bleeding,
and bilateral ovarian cysts. Her work-up and management demonstrates the importance of screening for
hypothyroidism in Down Syndrome, as well as considering the diagnosis of VWGS when evaluating a
patient with precocious puberty and an apparent intra-abdominal surgical process. Given the presence of
ovarian masses, a surgical emergency such as ovarian torsion or rupture must be ruled out. Even when
the diagnosis of VWGS is confirmed, practitioners must be vigilant to consider surgical intervention in
the presence of uncontrolled vaginal bleeding, hemodynamic instability, or failure of regression of
ovarian cysts with exogenous thyroid hormone replacement.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
This case presents a pediatric patientwith both Down Syndrome
(DS) and Van Wyk-Grumbach Syndrome (VWGS). To our knowl-
edge, similar cases have been presented only eight times before in
the literature [1]. This indicates that this case is a rare intersection
of the hypothyroidism associated with DS and VWGS and presents
several educational opportunities through detailed examination of
the case [2e4].
1. Case report
The patient is a 4-year 6-month African-American female with a
history of DS, seasonal allergies, and tympanostomy tube place-
ment who presented to an emergency department for evaluation of
an 8-day history of vaginal bleeding and abdominal distension. No
history of trauma, abuse, or vaginal foreign bodies. Mother of the
child reported no history of hematuria, hematochezia, or melena.
This patient was initially evaluated at an outside facility and found
to have bilateral adnexal structures on ultrasound, measuring
4.49  3.86 cm on the left and 4.46  6.09 cm on the right (Fig. 1).
She was transferred to our facility for further evaluation. Given the
patient's presentationwith abdominal distention, vaginal bleeding,
and bilateral ovarian masses, it was deemed most appropriate to
admit to the pediatric surgical service to rule out an oncologic
process or surgical emergency such as ovarian torsion or rupture.
Her vital signs were within normal limits and she was in no
apparent distress. She presented with Tanner stage II breast
development without galactorrhea, Tanner Stage II pubic hair, and
Tanner Stage I axillary development. She underwent a pelvic exam
under anesthesia, with no palpable masses on bimanual exam,
normal external genitalia, pink cervix, and normal rectum. Bone
age was delayed at 2 years and 6 months.
An abdominal CT scan was performed in the emergency
department to adequately evaluate for any acute intraabdominal
processes that would result in the patient's presentation. The CT
showed bilateral adnexal cysts with multiple septations, measuring
4.18 3 cm on the left and 4.35 5.36 cm on the right (Fig. 2). Upon
discussion with pediatric radiology and gynecology, an MRI was
recommended to better define the patient's ovarian, fallopian, and
uterine anatomy and to assess for any underlying oncologic pro-
cesses. MRI was performed under the same episode of anesthesia as
the patient's pelvic exam. The MRI verified the finding of bilateral
ovarian cysts with multiple septations (left 4.27  3.03 cm, right
* Corresponding author. Division of Pediatric Surgery, University of Florida, 1600
SW Archer Road, PO Box 100119, Gainesville, FL, 32610, USA.
E-mail address: janice.taylor@surgery.ufl.edu (J.A. Taylor).
Contents lists available at ScienceDirect
Journal of Pediatric Surgery Case Reports
journal homepage: www.jpscasereports .com
http://dx.doi.org/10.1016/j.epsc.2017.07.007
2213-5766/© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Journal of Pediatric Surgery Case Reports 25 (2017) 5e9
3.14 6.02 cm) and better defined an enlarged uterus and enlarged
vagina (Fig. 3).
Laboratory evaluation is summarized in Table 1. We found
elevated thyroid-stimulating hormone (TSH), low free thyroxine
(T4), and positive thyroid peroxidase (TPO) antibodies. Thyroglob-
ulin (Tg) levels were elevated but Tg antibodies were negative.
Hemoglobin was not measured. She had elevated estrogen and
prolactin; her luteinizing hormone (LH) and follicle-stimulating
hormone (FSH) were within normal limits. Beta-hCG was nega-
tive. Tumor markers were also obtained with normal cancer anti-
gen 19-9 (CA 19-9), and elevated cancer antigen 125(CA-125) and
alpha-fetoprotein (AFP).
Given her altered endocrine profile, she was evaluated by
endocrinology. The diagnosis of VWGS was made. She was started
on thyroid hormone replacement with levothyroxine at 50mcg
daily. Discussions with the patient's mother revealed no recent
thyroid testing by her primary care provider. The patient was set up
for outpatient follow up with a pediatric endocrinologist. She was
also evaluated by reproductive endocrinology, who stated that a
prolactinoma was an unlikely source of the elevated prolactin but
rather likely secondary to elevated thyroid-releasing hormone
(TRH). A brain MRI was not recommended given the alignment of
endocrine findings. Gynecologic oncology had also evaluated the
patient's pelvic masses and concluded that the ovarian cysts were
likely an endocrine-related consequence of the patient's hypothy-
roid state. Thus, all involved clinical teams agreed that therewas no
indication for surgical intervention. Her hemodynamic stability
also negated her needs for intervention.
Most recent contact with the patient's endocrinologist revealed
continued outpatient titration of the levothyroxine, and resolution
of vaginal bleeding and abdominal distention. Her growth stature is
improving and there has not been further progression of Tanner
staging. Given this, additional outpatient imaging has been de-
ferred to date. This patient presentation represents a unique op-
portunity to review the intersection of hypothyroidism, DS, and
VWGS, to avoid unnecessary operative intervention.
2. Discussion
2.1. Hypothyroidism & Down Syndrome
2.1.1. Epidemiology and screening protocols
Childrenwith DS are known to have an increased risk of thyroid
disease compared to the general population, with reported inci-
dence of 3e54%. The risk of thyroid disease increases with age to an
estimated prevalence of 30% among DS adults [5]. The American
Academy of Pediatrics (AAP) recommends a rigorous screening
protocol for thyroid function among children with DS. This starts
with the state newborn screen, which tests TSH and free T4. Pe-
diatricians should then repeat TSH levels at 6 months, 1 year, and
annually thereafter to age 21 [6]. Pediatricians are also advised to
screen for symptoms consistent with hypothyroidism, such as
lethargy, dry skin, and reduced growth velocity, which could be
masked by the DS phenotype.
2.1.2. Hypothyroidism presentations
DS patients can present with a range of hypothyroid disease,
including congenital hypothyroidism, subclinical hypothyroidism,
primary hypothyroidism, and autoimmune (Hashimoto's) thyroid-
itis. DS newborns are at a 1% risk of congenital hypothyroidism,
making the state newborn screen extremely important for timely
diagnosis and treatment [6]. In newborns without DS, the rate of
congenital hypothyroidism is estimated at 1:3000e4000 live
births, versus 1:141 among newborns with DS [7,8]. Other risk
factors for congenital hypothyroidism in DS include female sex, low
birth weight (<2000g), macrosomia (4500 g), and Hispanic,
Middle-Eastern, Asian, and Hawaiian ethnicities [7].
Subclinical hypothyroidism is considered an elevated TSHwith a
normal “compensated” T4 level [9]. DS neonates have been found to
have lower T4 concentrations andmildly elevated TSH compared to
non-DS neonates [10]. This is postulated to be secondary to delayed
hypothalamus-pituitary-thyroid maturation, which can be present
until the third decade of life [11].
Fig. 1. Patient's ultrasound showing bilateral cystic ovaries.
Fig. 2. CT scan showing patient's bilateral adnexal cysts with multiple septations.
Fig. 3. Patient MRI illustrating her enlarged uterus (white arrow).
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Patients with DS can also develop primary hypothyroidism, with
elevated TSH levels and low T4. DS patients' predisposition to hy-
pothyroidismmay be secondary to alterations of the thyroid as part
of the trisomy 21 phenotype. Thyroid hypoplasia is seen in the DS
population. Therefore, the increased incidence of hypothyroidism
with age in DS patients may be a reflection of increased metabolic
demands with increased body size [5,10].
The most common cause of primary hypothyroidism in DS pa-
tients is autoimmune, or Hashimoto's, thyroiditis. This appears to
be the cause of our patient's untreated hypothyroidism. Hashimo-
to's thyroiditis is the most common autoimmune disorder in DS
[5,12e14]. DS patients present at a younger age with negative
family history, and tend to have a significantly lower concentration
of TPO or Tg antibodies [12].
2.1.3. Treatment options
Once diagnosed, the hypothyroid DS patient is treated similarly
to a non-DS hypothyroid patient, with exogenous thyroid hormone
replacement and close clinical and laboratory follow-up.
2.2. Van Wyk-Grumbach Syndrome
2.2.1. Definition
VWGS is a constellation of symptoms first reported by Van Wyk
and Grumbach in 1960. They noted three cases of precocious
menstruation, breast development, and galactorrhea associated
with delayed bone age and hypothyroidism. The patients' symp-
toms and precocious puberty resolved with administration of
exogenous thyroid hormone, which VanWyk and Grumbach found
to be an essential component of this syndrome [15].
2.2.2. Previous case reports
After the initial report of VWGS, there have been numerous case
reports describing female pediatric patients presenting with pre-
cocious puberty (breast development, menarche, and/or galactor-
rhea) without adrenarche (no body odor, no pubic hair, no axillary
hair), elevated TSH, low T4, delayed bone age, and ovarian cysts
[1e4,16e28]. To our knowledge, there have been fewer than 10
previous case reports in the literature of patients with both DS and
VWGS [1e4]. Kumar et al. presented the only reviewed VWGS case
series without ovarian cysts on imaging [26]. Post-pubertal VWGS
patients presented with profound hypothyroidism, irregular
menses, and elevated prolactin levels with or without galactorrhea
[24,27]. Pre- and post-pubertal VWGS patients also presented with
reduced or arrested linear growth, with concern for “crossing
percentiles” that was confirmed with delayed bone age on
radiographs.
2.2.3. Pathophysiology
On their initial study, Van Wyk and Grumbach found one of
their patients to have an enlarged sella turcica without classical
visual field deficits suggesting an underlying etiology of pituitary
hyperplasia rather than adenoma. The enlarged sella turcica
resolved with exogenous thyroid hormone replacement, which
suggested the pituitary hyperplasia was associated with precocious
puberty. One of the patients in this study also had evidence of
Hashimoto's thyroiditis on thyroid biopsy. The authors concluded
that the patients in their case series had hypothyroidism due to
primary failure of the thyroid gland rather than a TSH deficiency
[15]. The reduced circulating thyroid hormone stimulated hyper-
plasia of TSH-secreting pituitary cells, leading to compression of the
pituitary stalk, disrupted inhibition of prolactin secretion, elevated
prolactin levels, and eventual elevation in TRH levels in response to
high prolactin levels [22,29]. The cross-sensitivity between TSH and
prolactin pituitary cells to TRH stimulation may further contribute
to elevated prolactin levels [21]. The elevated levels of prolactin
also can increase ovarian sensitivity to circulating LH and FSH and
decrease the frequency of gonadotropin-releasing hormone(GnRH)
pulses, thereby increasing FSH levels, reducing LH levels, and
increasing the risk of precocious puberty [30,31].
Several case reports of VWGS demonstrated elevated FSH levels
in their patients [4,20,22,25]. This led to the discovery that high
concentrations of TSH can act as a competitive antagonist for FSH at
ovarian FSH-receptors(FSH-R), demonstrating a possible link be-
tween hypothyroidism and precocious puberty. This is particularly
important in VWGS, with consistently elevated TSH in the prepu-
bertal patient [32,33]. TSH stimulation of FSH-R without concom-
itant LH stimulation leads to the clinical findings of thelarche and
gonadarche without adrenarche, consistent with the findings of
precocious puberty with no pubic or axillary hair in VWGS patients
[25]. The stimulation of ovarian FSH-receptors leads to follicle
recruitment, ovarian cysts, and elevated estrogen levels, which in
turn stimulates precocious puberty with breast development and
vaginal bleeding. The elevated estrogen levels can also reduce
prolactin inhibitory factor levels, which prevents negative feedback
on prolactin and increases the risk for galactorrhea [4,24].
Some VWGS patients present with elevated tumor markers. Our
case and several others report an elevated CA-125 level [21,24,27].
Importantly, CA-125 can be non-specific and elevated in endome-
triosis, uterine fibroids, and tubo-ovarian masses, which would fit
the clinical picture of VWGS [21]. Our patient also presented with
elevated AFP, which has been related to dysgerminomas and other
germ cell tumors. AFP has been found to normalize after thyroid
hormone replacement [21]. Another VWGS case with elevated AFP
resulted in oophorectomy, with pathology showing cystic follicles
without neoplasm [34]. Thus, the elevated tumor markers may not
Table 1
Patient lab values.
Lab Value on Presentation Interpretation Reference Range
TSH (mIU/L) 880.90 Elevated 0.27e4.20
Free T4 (ng/dL) 0.17 Low 0.93e1.79
TPO Ab (U/mL) 108.5 Elevated <0.3
Thyroglobulin Ab (IU/mL) <20 Normal <20
Thyroglobulin (ng/mL) 183.0 Elevated 2.0e35.0
Estradiol (pg/mL) [36] 113 Elevated <20-53
Prolactin (ng/mL) 134.8 Elevated 4.8e23.3
LH (mIU/mL) [36] <0.1 Normal <0.1e3.3
FSH (mIU/mL) [36] 5.7 Normal <0.1e7.1
Beta-hCG (IU/L) <1 Normal 0e5
CA 19-9 (U/mL) 26 Normal 0e35
CA-125 (U/mL) 68 Elevated 0e35
AFP (ng/mL) 24.5 Elevated 0.0e8.7
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be due to neoplasm, but rather are secondary to ovarian hyper-
stimulation and cyst formation. It is important to keep in mind that
bilateral ovarian cysts are likely secondary to an endocrine pa-
thology rather than malignancy, although it is possible to present
with VWGS and a unilateral ovarian cyst [21]. Knowledge of the
etiology of ovarian cysts and patterns of presentation is important
for the pediatric surgeon to prevent unnecessary operative
interventions.
Other symptoms of VWGS relate directly to the patient's pro-
found hypothyroidism. Myxedema can result in ascites, pleural
effusions, and pericardial effusions [17]. Ovarian pathology reports
after biopsy or ovarian cystectomy have shown myxedematous
infiltration into ovarian stroma [23,27]. Several VWGS case reports
found patients to be anemic, which could be secondary to vaginal
bleeding from precocious puberty, or directly due to their hypo-
thyroid state [16,22e24,27,35]. The delayed bone age seen in these
patients is classically associated with untreated hypothyroidism
[15]. Delayed bone age is also an important diagnostic clue for
VWGS, as most other causes of precocious puberty are associated
with advanced bone age [22]. In our patient, delayed bone age was
indicated on bone scan.
2.2.4. Treatment options
As suggested in Van Wyk and Grumbach's initial report, exog-
enous thyroid hormone replacement results in negative feedback
on pituitary hyperplasia, allowing hypothyroid symptoms to
regress [15]. Several reported cases treated VWGS with levothyr-
oxine and followed in the outpatient setting for normalization of
lab values and regression of ovarian cysts on serial imaging
[3,17,19e21,24,28]. Others followed for resolution of precocious
puberty and return of linear growth [4,16,26]. Vaginal bleeding can
persist in some patients after starting thyroid hormone replace-
ment due to endometrial hyperplasia from long-term estrogen
exposure. Treatment of persistent vaginal bleeding with progesto-
gen was successful in one case series [3].
Several authors have agreed that surgical intervention for
ovarian cystectomy or oophorectomy should be reserved for pa-
tients who may have associated ovarian torsion, ovarian rupture,
hemodynamic instability, or failure to regress with thyroid hor-
mone replacement. In one instance of failure to regress, a post-
pubertal patient underwent ovarian wedge resection which
showedmyxedema and hemorrhage in a benign ovarian cyst [27]. A
VWGS patient with severe anemia and hemodynamic instability
secondary to persistent vaginal bleeding necessitated bilateral
percutaneous ovarian cyst aspiration. The procedure was modeled
after aspiration techniques used to treat ovarian hyperstimulation
syndrome; the patient's vaginal bleeding resolved [22]. Given our
patient's hemodynamic stability and lack of evidence for an
emergent indication for surgery once VWGS was established, she
was treated with levothyroxine and has had resolution of her
menses-like symptoms and advanced Tanner staging. Overall,
operative management on ovarian findings in VWGS should be
reserved for lack of symptom resolution or normalization of
physiology.
3. Conclusion
Through our literature review, we explored the epidemiology,
pathophysiology, presentation, and treatment associated with both
hypothyroidism in DS and VWGS. Our case study emphasizes the
importance of adhering to the AAP's recommendations for
screening for hypothyroidism in DS patients, as there can be severe
consequences with the development of untreated hypothyroidism
in the pediatric patient. Surgery was not performed on this patient;
it was appropriately avoided by the recognition of VWGS. With
early recognition of the syndrome, CT or MRI could also have been
avoided, as ovarian cyst regression with thyroid hormone
replacement can be monitored with serial ultrasounds [4,20,23,25].
The size and complexity of the cysts contributed to concerns of
misdiagnosing the child without thorough imaging during her
evaluation. By examining this patient's presentation of VWGS
associated with untreated autoimmune hypothyroidism, we also
hope to encourage practitioners to maintain this rare syndrome in
their differential when presented with a pediatric patient with
apparent ovarian pathology, and experiencing inconsistent signs of
precocious puberty.
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